|
시장보고서
상품코드
2091795
소아 임상시험 시장 규모, 점유율 및 성장 분석 : 단계별, 연구 유형별, 치료 영역별, 연령층별, 서비스 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Pediatric Clinical Trials Market Size, Share, and Growth Analysis, By Phase, By Study Type, By Therapeutic Area, By Age Group, By Service Type, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 소아 임상시험 시장 규모는 2024년에 207억 달러로 평가되며, 2025년 218억 6,000만 달러에서 2033년까지 338억 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 5.6%로 성장할 것으로 전망되고 있습니다.
전 세계 소아 임상시험 시장은 의약품 개발 과정에서 종종 간과되기 쉬운 18세 미만 피험자의 의약품 안전성과 유효성 평가에 초점을 맞추며 발전해 나가고 있습니다. 소아에게는 특유의 약동학, 투여량, 질환 프로파일이 있으며, 성인 데이터만으로는 불충분하므로 이 시장은 매우 중요합니다. 규제 당국의 인센티브가 성장을 지원하며, 후원사들이 귀중한 소아 데이터를 수집하도록 장려하고 있습니다. 천식이나 척수성 근위축증 치료 등 성공적인 사례들은 이 접근법의 장점을 여실히 보여주고 있습니다. 규제의 조화를 통해 지역 간 지침이 통일됨에 따라 기업이 임상시험을 효율화하고 비용을 절감할 수 있게 됨으로써 시장의 효율성이 향상되고 있습니다. 이로 인해 생명공학 기업의 시장 진입이 촉진되고, 혁신이 가속화되며, 연구 조직이 확대되는 한편, 서비스 제공업체에게는 새로운 수익 기회가 창출되고 있습니다.
세계 소아 임상시험 시장의 성장 요인
소아 질환에 대한 인식이 높아짐에 따라 표적 치료제에 대한 제약 투자가 크게 촉진되고 있으며, 제약사들은 규제상의 인센티브를 활용하면서 미충족 의료 수요를 해결하기 위한 소아 임상시험을 시작하고 있습니다. 이러한 노력은 소아를 대상으로 한 연구의 파이프라인을 확대할 뿐만 아니라, 혁신적인 치료법이 조기에 시장에 진출할 수 있는 길을 열어주고 있습니다. 또한 이러한 노력은 학술기관, 계약 연구 기관(CRO), 환자 지원 단체 간의 협력을 촉진하고, 피험자 등록 절차를 간소화하며, 소아 대상 임상시험 설계의 적절성을 높이는 효율적인 네트워크 구축에 기여하고 있습니다. 이러한 포괄적인 전략은 데이터의 질을 향상시키고 심사를 신속화함으로써, 소아 임상 연구에 대한 지속적인 투자와 참여를 촉진하고 있습니다.
세계 소아 임상시험 시장의 제약 요인
전 세계 소아 임상시험 시장은 취약한 입장에 있는 소아 피험자를 보호하기 위해 윤리심사위원회가 제시한 엄격한 요건으로 인해 큰 제약을 받고 있습니다. 이러한 위원회들은 엄격한 동의 획득 절차와 철저한 위험-이익 평가를 의무화하고 있으며, 이로 인해 연구 시작이 지연되고 있습니다. 그 결과, 후원사는 종종 프로토콜을 반복적으로 수정하거나, 전문적인 모니터링 전략을 시행하거나, 보호자와의 지속적인 소통을 유지해야 하는 경우가 많으며, 이 모든 것이 업무의 복잡성을 가중시키고 있습니다. 이로 인해 임상시험 기관의 가동 개시까지 걸리는 기간이 길어지거나 필요한 자원이 증가할 가능성이 있으며, 특히 규정 준수 체계를 충분히 갖추지 못한 중소기업 등의 의뢰사의 투자 의욕을 저해하게 되어, 궁극적으로는 시장의 성장을 저해하고 임상시험 기간을 장기화시키는 요인이 됩니다.
세계 소아 임상시험 시장의 동향
전 세계 소아 임상시험 시장에서는 AI를 활용한 시험 설계에 대한 뚜렷한 추세가 나타나고 있으며, 이는 소아 집단을 대상으로 한 시험의 수행 방식에 혁명을 일으키고 있습니다. 인공지능의 도입을 통해 보다 효과적인 임상시험 프로토콜 수립이 촉진되고, 피험자 모집 전략이 강화되며, 적응형 투여 방식이 최적화됩니다. 기계학습을 활용하여 실제 환경의 건강 데이터와 유전 정보를 분석함으로써, 연구자들은 안전성 신호를 보다 신속하게 파악하고 위험을 줄일 수 있으므로, 연구 프로토콜 수정 필요성을 최소화할 수 있습니다. 이러한 추세는 임상시험 일정을 앞당기고 이해관계자들의 신뢰를 높일 뿐만 아니라, 소아 연구에 있으며, 필수적인 윤리적 고려 사항에도 부응하고 있으며, AI는 전 세계 소아 보건 구상을 추진하는 데 있으며, 필수적인 툴이 되고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 소아 임상시험 시장 규모 : 단계별
세계의 소아 임상시험 시장 규모 : 연구 유형별
세계의 소아 임상시험 시장 규모 : 치료 영역별
세계의 소아 임상시험 시장 규모 : 연령층별
세계의 소아 임상시험 시장 규모 : 서비스 유형별
세계의 소아 임상시험 시장 규모 : 최종사용자별
세계의 소아 임상시험 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.22Global Pediatric Clinical Trials Market size was valued at USD 20.7 Billion in 2024 and is poised to grow from USD 21.86 Billion in 2025 to USD 33.8 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).
The global pediatric clinical trials market is evolving, focusing on assessing the safety and efficacy of medications in individuals under 18, a demographic often overlooked in drug development. This market is critical due to the unique pharmacokinetics, dosing, and disease profiles in children that make adult data inadequate. Incentives from regulatory bodies have stimulated growth, encouraging sponsors to generate valuable pediatric data. Successful case studies, such as treatments for asthma and spinal muscular atrophy, highlight the benefits of this approach. Regulatory harmonization enhances market efficiency by aligning guidelines across regions, allowing companies to streamline trials and cut costs. This has attracted biotech firms, driving innovation and expanding research organizations while creating new revenue opportunities for service providers.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Clinical Trials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pediatric Clinical Trials Market Segments Analysis
Global pediatric clinical trials market is segmented by phase, study type, therapeutic area, age group, service type, end user and region. Based on phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on study type, the market is segmented into Interventional Trials and Observational Trials. Based on therapeutic area, the market is segmented into Oncology, Infectious Diseases, Neurology, Respiratory Disorders, Rare Diseases and Others. Based on age group, the market is segmented into Neonates, Infants, Children and Adolescents. Based on service type, the market is segmented into Clinical Trial Management, Patient Recruitment, Data Management & Analytics, Regulatory Services and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pediatric Clinical Trials Market
The increasing awareness of childhood diseases is significantly stimulating pharmaceutical investments in targeted therapies, prompting sponsors to launch pediatric trials aimed at addressing unmet medical needs while benefiting from regulatory incentives. This focus not only expands the pipeline of studies designed for younger populations but also paves the way for earlier market entry of innovative treatments. Additionally, such initiatives promote collaborations among academic institutions, contract research organizations, and patient advocacy groups, which help establish efficient networks that simplify the enrollment process and enhance the relevance of trial designs for children. These comprehensive strategies improve data quality and expedite review, encouraging ongoing investment and participation in pediatric clinical research.
Restraints in the Global Pediatric Clinical Trials Market
The Global Pediatric Clinical Trials market faces significant restraints due to the rigorous requirements set by ethical review committees aimed at protecting vulnerable child participants. These committees enforce strict consent processes and thorough risk-benefit evaluations, which delay the initiation of studies. As a result, sponsors often have to make multiple protocol adjustments, implement specialized monitoring strategies, and maintain constant communication with guardians, all of which add to operational complexity. This can lead to longer site activation periods and increased resource demands, discouraging investment from sponsors, especially small companies that may not have dedicated compliance infrastructure, ultimately hindering market growth and prolonging study durations.
Market Trends of the Global Pediatric Clinical Trials Market
The Global Pediatric Clinical Trials market is witnessing a significant trend towards AI-driven trial design, revolutionizing the way studies are conducted for child populations. The incorporation of artificial intelligence facilitates the development of more effective study protocols, enhances patient recruitment strategies, and optimizes adaptive dosing approaches. By leveraging machine learning to analyze real-world health data and genetic information, researchers can more quickly identify safety signals and mitigate risks, thereby minimizing the need for protocol amendments. This trend not only accelerates trial timelines and boosts stakeholder confidence but also addresses ethical considerations essential in pediatric research, making AI a vital tool in advancing global pediatric healthcare initiatives.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & Buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global Pediatric Clinical Trials Market Size by Phase & CAGR (2026-2033)
- Market Overview
- Phase I
- Phase II
- Phase III
- Phase IV
Global Pediatric Clinical Trials Market Size by Study Type & CAGR (2026-2033)
- Market Overview
- Interventional Trials
- Observational Trials
Global Pediatric Clinical Trials Market Size by Therapeutic Area & CAGR (2026-2033)
- Market Overview
- Oncology
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Rare Diseases
- Others
Global Pediatric Clinical Trials Market Size by Age Group & CAGR (2026-2033)
- Market Overview
- Neonates
- Infants
- Children
- Adolescents
Global Pediatric Clinical Trials Market Size by Service Type & CAGR (2026-2033)
- Market Overview
- Clinical Trial Management
- Patient Recruitment
- Data Management & Analytics
- Regulatory Services
- Others
Global Pediatric Clinical Trials Market Size by End User & CAGR (2026-2033)
- Market Overview
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
Global Pediatric Clinical Trials Market Size & CAGR (2026-2033)
- North America (Phase, Study Type, Therapeutic Area, Age Group, Service Type, End User)
- US
- Canada
- Europe (Phase, Study Type, Therapeutic Area, Age Group, Service Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Phase, Study Type, Therapeutic Area, Age Group, Service Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Phase, Study Type, Therapeutic Area, Age Group, Service Type, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Phase, Study Type, Therapeutic Area, Age Group, Service Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- IQVIA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Labcorp Drug Development
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Parexel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Premier Research
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Worldwide Clinical Trials
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- KCR
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veristat
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CTI Clinical Trial and Consulting Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caidya
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PSI CRO
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Linical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Precision for Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PPD Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NAMSA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
